Validation of 3‐ and 5‐point severity scales to assess ARIA‐E

por Bracoud, Luc, Klein, Gregory, Lyons, Marco, Scelsi, Marzia A., Wojtowicz, Jakub, Bullain, Szofia, Purcell, Derk, Fiebach, Jochen B., Barakos, Jerome, Suhy, Joyce
Publicado 2023

Comparing ARIA‐E severity scales and effects of treatment management thresholds

por Klein, Gregory, Scelsi, Marzia A., Barakos, Jerome, Fiebach, Jochen B., Bracoud, Luc, Suhy, Joyce, Delmar, Paul, Lyons, Marco, Wojtowicz, Jakub, Bullain, Szofia, Barkhof, Frederik, Purcell, Derk
Publicado 2022

In silico exploration of amyloid‐related imaging abnormalities in the gantenerumab open‐label extension trials using a semi‐mechanistic model

por Aldea, Roxana, Grimm, Hans Peter, Gieschke, Ronald, Hofmann, Carsten, Lott, Dominik, Bullain, Szofia, Delmar, Paul, Klein, Gregory, Lyons, Marco, Piazza, Fabrizio, Carare, Roxana O., Mazer, Norman A.
Publicado 2022